Compare INDRAPRASTHA MEDICAL with TRANSGENE BI - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDRAPRASTHA MEDICAL vs TRANSGENE BI - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDRAPRASTHA MEDICAL TRANSGENE BI INDRAPRASTHA MEDICAL/
TRANSGENE BI
 
P/E (TTM) x 16.8 -2.5 - View Chart
P/BV x 2.7 0.8 335.6% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 INDRAPRASTHA MEDICAL   TRANSGENE BI
EQUITY SHARE DATA
    INDRAPRASTHA MEDICAL
Mar-20
TRANSGENE BI
Mar-20
INDRAPRASTHA MEDICAL/
TRANSGENE BI
5-Yr Chart
Click to enlarge
High Rs525 1,005.8%   
Low Rs272 1,365.7%   
Sales per share (Unadj.) Rs90.60 17,166,818.9%  
Earnings per share (Unadj.) Rs4.8-1.4 -328.9%  
Cash flow per share (Unadj.) Rs8.4-0.1 -5,944.4%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs29.24.3 677.5%  
Shares outstanding (eoy) m91.6775.77 121.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.47,815.1 0.0%   
Avg P/E ratio x8.4-2.5 -336.2%  
P/CF ratio (eoy) x4.8-25.7 -18.6%  
Price / Book Value ratio x1.40.8 163.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,660274 1,338.1%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1393 73,769.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m8,3080 20,769,200.0%  
Other income Rs m72 383.8%   
Total revenues Rs m8,3152 456,843.4%   
Gross profit Rs m864-9 -10,010.5%  
Depreciation Rs m33099 333.1%   
Interest Rs m594 1,553.0%   
Profit before tax Rs m482-110 -439.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m460-   
Profit after tax Rs m436-110 -398.0%  
Gross profit margin %10.4-21,584.0 -0.0%  
Effective tax rate %9.50-   
Net profit margin %5.3-274,056.0 -0.0%  
BALANCE SHEET DATA
Current assets Rs m1,4157 20,743.7%   
Current liabilities Rs m1,396137 1,018.7%   
Net working cap to sales %0.2-325,549.5 -0.0%  
Current ratio x1.00 2,036.3%  
Inventory Days Days212,136,276 0.0%  
Debtors Days Days35771 4.5%  
Net fixed assets Rs m3,0751,661 185.2%   
Share capital Rs m917758 121.0%   
"Free" reserves Rs m1,761-431 -408.7%   
Net worth Rs m2,678327 819.6%   
Long term debt Rs m043 0.0%   
Total assets Rs m4,4901,668 269.3%  
Interest coverage x9.1-27.8 -32.9%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x1.90 7,713,513.0%   
Return on assets %11.0-6.3 -173.9%  
Return on equity %16.3-33.6 -48.6%  
Return on capital %20.2-28.6 -70.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m1,4080-   
Fx outflow Rs m3440-   
Net fx Rs m1,0640-   
CASH FLOW
From Operations Rs m8651 62,195.0%  
From Investments Rs m-402NA-  
From Financial Activity Rs m-427-2 21,372.0%  
Net Cashflow Rs m35-1 -5,760.7%  

Share Holding

Indian Promoters % 49.4 23.6 208.9%  
Foreign collaborators % 1.6 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.0 76.4 64.2%  
Shareholders   59,093 10,543 560.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDRAPRASTHA MEDICAL With:   DR LALCHANDANI LABS  CHOKSI LAB.  TEJNAKSH HEALTHCARE  CHENNAI MEENAKSHI   AASHKA HOSPITALS  



Today's Market

Sensex Slumps 700 Points from Day's High to End Lower; Tata Steel & SBI Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0% (Quarterly Result Update)

May 26, 2020 | Updated on May 26, 2020

For the quarter ended March 2020, INDRAPRASTHA MEDICAL has posted a net profit of Rs 65 m (down 9.0% YoY). Sales on the other hand came in at Rs 2 bn (up 0.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (2QFY20); Net Profit Up 133.6% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 179 m (up 133.6% YoY). Sales on the other hand came in at Rs 2 bn (up 8.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL 2018-19 Annual Report Analysis (Annual Result Update)

Oct 18, 2019 | Updated on Oct 18, 2019

Here's an analysis of the annual report of INDRAPRASTHA MEDICAL for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of INDRAPRASTHA MEDICAL. Also includes updates on the valuation of INDRAPRASTHA MEDICAL.

INDRAPRASTHA MEDICAL Announces Quarterly Results (4QFY20); Net Profit Down 9.0% (Quarterly Result Update)

May 26, 2020 | Updated on May 26, 2020

For the quarter ended March 2020, INDRAPRASTHA MEDICAL has posted a net profit of Rs 65 m (down 9.0% YoY). Sales on the other hand came in at Rs 2 bn (up 0.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

INDRAPRASTHA MEDICAL Announces Quarterly Results (2QFY20); Net Profit Up 133.6% (Quarterly Result Update)

Nov 8, 2019 | Updated on Nov 8, 2019

For the quarter ended September 2019, INDRAPRASTHA MEDICAL has posted a net profit of Rs 179 m (up 133.6% YoY). Sales on the other hand came in at Rs 2 bn (up 8.0% YoY). Read on for a complete analysis of INDRAPRASTHA MEDICAL's quarterly results.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider(Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore(Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

The Top Stocks to Sell in this Bull Market(Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

How to Create a Second Income from Trading(Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDRAPRASTHA MEDICAL SHARE PRICE


Sep 17, 2021 (Close)

TRACK INDRAPRASTHA MEDICAL

  • Track your investment in INDRAPRASTHA MEDICAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDRAPRASTHA MEDICAL

INDRAPRASTHA MEDICAL - MAX HEALTHCARE INSTITUTE COMPARISON

COMPARE INDRAPRASTHA MEDICAL WITH

MARKET STATS